These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18313983)

  • 41. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
    Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
    Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severity of acute heart failure in men according to diabetes mellitus: the role of testosterone and renal dysfunction.
    Čulić V; Bušić Ž
    Int J Cardiol; 2013 Oct; 168(5):5039-41. PubMed ID: 23948113
    [No Abstract]   [Full Text] [Related]  

  • 44. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure.
    Al-Najjar Y; Goode KM; Zhang J; Cleland JG; Clark AL
    Eur J Heart Fail; 2009 Dec; 11(12):1155-62. PubMed ID: 19926599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of endothelial microparticles in patients with heart failure.
    Nozaki T; Sugiyama S; Sugamura K; Ohba K; Matsuzawa Y; Konishi M; Matsubara J; Akiyama E; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    Eur J Heart Fail; 2010 Nov; 12(11):1223-8. PubMed ID: 20817695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.
    Mohammed AA; van Kimmenade RR; Richards M; Bayes-Genis A; Pinto Y; Moore SA; Januzzi JL
    Circ Heart Fail; 2010 May; 3(3):354-61. PubMed ID: 20332419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
    Shelton RJ; Goode K; Cleland JG
    Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
    [No Abstract]   [Full Text] [Related]  

  • 51. [Significances of NT-proBNP and hs-CRP in heart failure].
    Wang L; Hu SY; Wu X; Jü XF
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(23):1635-6. PubMed ID: 20979755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing prognosis in heart failure: you can see a lot if you look, but more if you look again.
    Squire I
    Eur Heart J; 2008 Apr; 29(8):959-60. PubMed ID: 18349028
    [No Abstract]   [Full Text] [Related]  

  • 53. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
    Troughton RW; Frampton CM; Nicholls MG
    J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
    [No Abstract]   [Full Text] [Related]  

  • 55. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
    Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.
    Walsh R; Boyer C; LaCorte J; Parnell V; Sison C; Chowdhury D; Ojamaa K
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):98-105. PubMed ID: 18179925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations > 100 pg/ml: comparison of a clinical model with brain natriuretic peptide concentrations.
    Kellett J
    Heart; 2006 Oct; 92(10):1512-3. PubMed ID: 16973805
    [No Abstract]   [Full Text] [Related]  

  • 58. N-terminal pro-B-type natriuretic peptide and sudden cardiac death risk: implications for primary prevention of sudden cardiac death.
    Albert CM
    Heart Rhythm; 2011 Feb; 8(2):234-5. PubMed ID: 21145430
    [No Abstract]   [Full Text] [Related]  

  • 59. B-type natriuretic peptide testing in the general population: are we ready for prime time?
    Ho JE; Levy D
    J Am Coll Cardiol; 2010 May; 55(19):2148-9. PubMed ID: 20447540
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of novel biomarkers in heart failure: how and why?
    Koza Y
    Int J Cardiol; 2014; 172(1):e194-5. PubMed ID: 24444487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.